Ligand-activated peroxisome proliferator-activated receptor-δ and -γ inhibit lipopolysaccharide-primed release of high mobility group box 1 through upregulation of SIRT1

• Published in: Cell death & disease 2014-10, Vol.5 (10), p.e1432-e1432
• Main Authors: Hwang, J S, Lee, W J, Kang, E S, Ham, S A, Yoo, T, Paek, K S, Lim, D S, Do, J T, Seo, H G
• Format: Article
• Language: English
• Subjects: 631/250/256; 631/80/86; Animals; Antibodies; Biochemistry; Biomedical and Life Sciences; Cell Biology; Cell Culture; Cell Line; Down-Regulation; HMGB1 Protein - genetics; HMGB1 Protein - metabolism; Humans; Immunology; Life Sciences; Lipopolysaccharides - metabolism; Macrophages - enzymology; Macrophages - metabolism; Mice; Mice, Knockout; Original; original-article; p300-CBP Transcription Factors - genetics; p300-CBP Transcription Factors - metabolism; PPAR delta - genetics; PPAR delta - metabolism; PPAR gamma - genetics; PPAR gamma - metabolism; Sirtuin 1 - genetics; Sirtuin 1 - metabolism; Up-Regulation
• ISSN: 2041-4889; 2041-4889
• DOI: 10.1038/cddis.2014.406

Peroxisome proliferator-activated receptors (PPARs) inhibit lipopolysaccharide (LPS)-primed release of high mobility group box 1 (HMGB1), a late proinflammatory mediator, but the underlying molecular mechanism is not completely understood. In this study, we demonstrated that the inhibition of HMGB1 release by PPAR- δ and - γ is associated with the deacetylase activity of SIRT1. Ligand-activated PPAR- δ and - γ inhibited LPS-primed release of HMGB1, concomitant with elevation in SIRT1 expression and promoter activity. These effects were significantly reduced in the presence of small interfering (si)RNAs against PPAR, indicating that PPAR- δ and - γ are involved in both HMGB1 release and SIRT1 expression. In addition, modulation of SIRT1 expression and activity by siRNA or chemicals correspondingly influenced the effects of PPARs on HMGB1 release, suggesting a mechanism in which SIRT1 modulates HMGB1 release. Furthermore, we showed for the first time that HMGB1 acetylated in response to LPS or p300/CBP-associated factor (PCAF) is an effective substrate for SIRT1, and that deacetylation of HMGB1 is responsible for blockade of HMGB1 release in macrophages. Finally, acetylation of HMGB1 was elevated in mouse embryonic fibroblasts from SIRT1 -knockout mice, whereas this increase was completely reversed by ectopic expression of SIRT1. These results indicate that PPAR-mediated upregulation of SIRT1 modulates the status of HMGB1 acetylation, which, in turn, has a critical role in the cellular response to inflammation through deacetylation-mediated regulation of HMGB1 release.